Description
Tramix (Tranexamic Acid) Solution for Injections 100 mg/ml. 5 ml. Vials №5
Ingredients
- Active ingredient: Tranexamic acid
- Inactive ingredients may include water for injection
Dosage
Dosage: The usual dose of Tramix for adults is 1 gram (10 ml) by slow intravenous injection, to be repeated if necessary. Dosage may vary based on the condition being treated.
Indications
Indications: Tramix is indicated for the treatment of heavy menstrual bleeding, prevention of excessive bleeding during surgery, and management of bleeding disorders.
Contraindications
Contraindications: Do not use Tramix if you have a history of blood clots, color vision disorders, or if you are allergic to tranexamic acid.
Directions
Directions: Tramix is for intravenous use only. It should be administered by a healthcare professional in a clinical setting.
Scientific Evidence
Tranexamic acid, the active ingredient in Tramix, works by inhibiting the breakdown of blood clots, thereby reducing bleeding. Studies have shown that tranexamic acid is effective in reducing blood loss during surgery and in the treatment of heavy menstrual bleeding.
Additional Information
- Tramix is a well-tolerated medication with a good safety profile when used as directed.
- It is important to inform your healthcare provider about any medications you are currently taking to avoid potential drug interactions.
- Store Tramix at the recommended temperature and out of reach of children.
Pharmacological Effects: Tranexamic acid exerts its pharmacological action by blocking the lysine binding sites on plasminogen molecules. This inhibition prevents the conversion of plasminogen to plasmin, thereby reducing fibrinolysis and promoting clot stability.
Clinical Trials: Clinical trials have demonstrated the efficacy of tranexamic acid in various medical conditions, including trauma, postpartum hemorrhage, and orthopedic surgery.
